|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Net loss from divestitures and sale of assets | |||||
| Impairment of long-lived assets | |||||
| Other restructuring charges | |||||
| Restructuring charges (recoveries), net | |||||
| Loss (gain) on foreign exchange | |||||
| Total operating expenses | |||||
| Operating income (loss) | |||||
| Other income, net: | |||||
| Interest income, net | |||||
| Other income, net | |||||
| Total other income | |||||
| Income (loss) before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net (loss) income | |||||
| Less: net income attributable to non-controlling interests | |||||
| Net income (loss) | |||||
| Net income (loss) per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...